Your browser doesn't support javascript.
loading
Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression.
Englinger, Bernhard; Lötsch, Daniela; Pirker, Christine; Mohr, Thomas; van Schoonhoven, Sushilla; Boidol, Bernd; Lardeau, Charles-Hugues; Spitzwieser, Melanie; Szabó, Pál; Heffeter, Petra; Lang, Irene; Cichna-Markl, Margit; Grasl-Kraupp, Bettina; Marian, Brigitte; Grusch, Michael; Kubicek, Stefan; Szakács, Gergely; Berger, Walter.
Afiliação
  • Englinger B; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Lötsch D; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Pirker C; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Mohr T; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • van Schoonhoven S; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Boidol B; CeMM Research Center for Molecular Medicine of The Austrian Academy of Sciences, Vienna, Austria.
  • Lardeau CH; CeMM Research Center for Molecular Medicine of The Austrian Academy of Sciences, Vienna, Austria.
  • Spitzwieser M; Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
  • Szabó P; Institute of Organic Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
  • Heffeter P; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Lang I; Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
  • Cichna-Markl M; Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
  • Grasl-Kraupp B; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Marian B; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Grusch M; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Kubicek S; CeMM Research Center for Molecular Medicine of The Austrian Academy of Sciences, Vienna, Austria.
  • Szakács G; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
  • Berger W; Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
Oncotarget ; 7(31): 50161-50179, 2016 Aug 02.
Article em En | MEDLINE | ID: mdl-27367030
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Receptores de Endotelina / Resistencia a Medicamentos Antineoplásicos / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Indóis / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Receptores de Endotelina / Resistencia a Medicamentos Antineoplásicos / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Indóis / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article